Longevity Startup Doses First Human in Bid to Reverse Age-Related Sight Loss
Culture Index
Score Breakdown
Relevance
3/25
Freshness
25/25
Authority
18/20
Brand Signal
6/15
Depth
3/15
5-Axis Cultural Radar
The FDA recently approved the cellular rejuvenation therapy ER-100 for human clinical trials. While vision is the first target, it could have applications for a variety of age-related disease.
